𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients

✍ Scribed by Kristiansen, G; Schlüns, K; Yongwei, Y; Denkert, C; Dietel, M; Petersen, I

Book ID
109997452
Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
216 KB
Volume
88
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of miR-374a as a prognost
Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer
✍ Urmo Võsa; Tõnu Vooder; Raivo Kolde; Krista Fischer; Kristjan Välk; Neeme Tõniss 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

## Abstract Lung cancer is one of the deadliest types of cancer proven by the poor survival and high relapse rates after surgery. Recently discovered microRNAs (miRNAs), small noncoding RNA molecules, play a crucial role in modulating gene expression networks and are directly involved in the progre

Neuroendocrine differentiation is an ind
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma
✍ Jeffrey T. Schleusener; Henry D. Tazelaar; Sin-ho Jung; Stephen S. Cha; Peter J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 736 KB

## BACKGROUND. Neuroendocrine differentiation can be identified in 10-30% of patients with nonsmall cell lung carcinoma (NSCLC) by immunohistochemical or electron microscopic techniques. However, its clinical significance is not well established. ## METHODS. Tumors from 107 patients with Stage

Overexpression of eIF5A-2 is an adverse
Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non–small cell lung cancer patients
✍ Li-Ru He; Hong-Yun Zhao; Bin-Kui Li; Yan-Hui Liu; Meng-Zhong Liu; Xin-Yuan Guan; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 624 KB

## Abstract We have previously isolated an oncogene __EIF5A2__ (eukaryotic initiation factor 5A2) from a frequently amplified region at 3q of a primary ovarian cancer cell line, and demonstrated its impact on prognosis in human ovarian cancer. Amplification of chromosome 3q has also been detected f